- Stock Analysis
- Analyst Forecasts
- Chart
- Competitors
- Earnings
- Financials
- Headlines
- Insider Trades
- Options Chain
- Ownership
- SEC Filings
- Short Interest
- Trends
SpringWorks Therapeutics Latest Earnings Summary
- Actual EPS
(Nov. 12) - -$0.72 Beat By $0.03
- Consensus EPS
(Nov. 12) - -$0.75
SpringWorks Therapeutics issued Q3 2024 earnings on November 12, 2024, reporting an EPS of -$0.72, which beat the consensus estimate of -$0.75 by $0.03. Quarterly revenue rose 4810.0% year-over-year to $49.10 million, below analysts' expectations of $53.28 million. With a trailing EPS of -$3.88, SpringWorks Therapeutics' earnings are expected to grow next year, from ($3.12) to ($2.08) per share.
Get SpringWorks Therapeutics Earnings Alerts
Want to stay updated on the latest earnings announcements and upcoming reports? Sign up for Earnings360's daily newsletter to receive timely earnings updates on SpringWorks Therapeutics and other key companies, straight to your inbox.
Sign Up
SWTX Earnings Estimates and Actuals by Quarter
The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.
SWTX Estimated and Actual Revenue by Quarter
The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.
SpringWorks Therapeutics Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 2 | -$1.27 | -$1.10 | -$1.19 |
Q2 2024 | 2 | -$1.44 | -$0.99 | -$1.22 |
Q3 2024 | 2 | -$0.74 | -$0.60 | -$0.67 |
Q4 2024 | 2 | -$0.76 | -$0.59 | -$0.68 |
FY 2024 | 8 | -$4.21 | -$3.28 | -$3.75 |
Q1 2025 | 2 | -$0.75 | -$0.44 | -$0.60 |
Q2 2025 | 2 | -$0.71 | -$0.23 | -$0.47 |
Q3 2025 | 2 | -$0.60 | -$0.03 | -$0.32 |
Q4 2025 | 2 | -$0.46 | $0.11 | -$0.18 |
FY 2025 | 8 | ($2.52) | ($0.59) | ($1.56) |
SpringWorks Therapeutics Earnings History by Quarter
Export to Excel
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | GAAP EPS | Revenue Estimate | Actual Revenue | Details |
---|---|---|---|---|---|---|---|---|
11/12/2024 | Q3 2024 | -$0.75 | -$0.72 | +$0.03 | -$0.72 | $53.28M | $49.10M | |
8/7/2024 | Q2 2024 | -$1.12 | -$0.54 | +$0.58 | -$0.54 | $34.42M | $59.73M | |
5/2/2024 | Q1 2024 | -$1.17 | -$1.18 | -$0.01 | -$1.18 | $12.07M | $21.00M | |
2/27/2024 | Q4 2023 | -$1.24 | -$1.44 | -$0.20 | -$1.44 | $1.26M | $5.45M | |
11/2/2023 | Q3 2023 | -$1.31 | -$1.27 | +$0.04 | -$1.27 | - | - | |
8/2/2023 | Q2 2023 | -$1.26 | -$1.25 | +$0.01 | -$1.25 | - | - | |
Get the Latest News and Ratings for SWTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for SpringWorks Therapeutics and its competitors with MarketBeat's FREE daily newsletter. | ||||||||
5/3/2023 | Q1 2023 | -$1.10 | -$1.18 | -$0.08 | -$1.18 | - | - | |
2/28/2023 | Q4 2022 | -$1.01 | -$1.19 | -$0.18 | -$1.19 | - | - |
SpringWorks Therapeutics Earnings - Frequently Asked Questions
SpringWorks Therapeutics (NASDAQ:SWTX) last announced its quarterly earning data on Tuesday, November 12, 2024. Learn more on SWTX's earnings history.
In the previous quarter, SpringWorks Therapeutics (NASDAQ:SWTX) reported ($0.72) earnings per share (EPS) to beat the analysts' consensus estimate of ($0.75) by $0.03. Learn more on analysts' earnings estimate vs. SWTX's actual earnings.
The conference call for SpringWorks Therapeutics's latest earnings report can be listened to online.
Listen to Conference CallThe conference call transcript for SpringWorks Therapeutics's latest earnings report can be read online.
Read TranscriptSpringWorks Therapeutics's earnings report can be found in their filing with the SEC.
View SEC filingSpringWorks Therapeutics (NASDAQ:SWTX) has a recorded annual revenue of $135.49 million.
SpringWorks Therapeutics (NASDAQ:SWTX) has a recorded net income of -$325.10 million. SWTX has generated -$3.88 earnings per share over the last four quarters.
SpringWorks Therapeutics's earnings are expected to grow from ($3.12) per share to ($2.08) per share in the next year.
More Earnings Resources from MarketBeat
Related Companies
- Dr. Reddy's Laboratories Earnings Results
- Vaxcyte Earnings Results
- Catalent Earnings Results
- Qiagen Earnings Results
- Intra-Cellular Therapies Earnings Results
- Roivant Sciences Earnings Results
- Revolution Medicines Earnings Results
- Ascendis Pharma A/S Earnings Results
- Legend Biotech Earnings Results
- Nuvalent Earnings Results
Earnings Tools
- Today's Earnings
- Tomorrow's Earnings
- Next Week's Earnings
- Upcoming Earnings Calls
- Earnings Newsletter
- Earnings Call Transcripts
- Corporate Guidance
- Earnings Screener
Earnings By Country
- U.S. Earnings Reports
- Canadian Earnings Reports
- U.K. Earnings Reports
Latest Articles
- Alibaba Stock: Why Earnings Make It a Buy Despite the Recent Dip
- MercadoLibre Down 23% After Missed Earnings: Time to Buy the Dip?
- Roblox Stock Soars 22% After Q3 Earnings – A Turning Point Ahead?
- Apple Earnings - When Really Good Just Isn’t Good Enough
- Roblox Stock Set for More Gains After Strong Earnings Report
- Amazon: Why Analysts Think It's a Solid Buy Ahead of Earnings
- Lam Research Proves Analysts Wrong with a Strong Earnings Report
This page (NASDAQ:SWTX) was last updated on 12/11/2024 by MarketBeat.com Staff
From Our Partners